This is a Validated Antibody Database (VAD) review about human CA9, based on 21 published articles (read how Labome selects the articles), using CA9 antibody in all methods. It is aimed to help Labome visitors find the most suited CA9 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CA9 synonym: CAIX; MN

Abcam
domestic rabbit polyclonal
  • immunohistochemistry; human; loading ...; fig s5c
Abcam CA9 antibody (abcam, ab184006) was used in immunohistochemistry on human samples (fig s5c). Oncogenesis (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:1000; fig 2g
Abcam CA9 antibody (Abcam, ab15086) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig 2g). Cancer Res (2021) ncbi
mouse monoclonal (CA9/781)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 5a
Abcam CA9 antibody (Abcam, ab216021) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 5a). Oncol Lett (2020) ncbi
mouse monoclonal (2D3)
  • immunohistochemistry - paraffin section; human; 1:80; loading ...; fig 4a
Abcam CA9 antibody (Abcam, ab107257) was used in immunohistochemistry - paraffin section on human samples at 1:80 (fig 4a). Oncol Rep (2020) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; loading ...; fig 3a
  • immunohistochemistry; human; loading ...; fig 5a
  • western blot; human; loading ...; fig 6d, s2c
Abcam CA9 antibody (Abcam, ab184006) was used in immunocytochemistry on human samples (fig 3a), in immunohistochemistry on human samples (fig 5a) and in western blot on human samples (fig 6d, s2c). Sci Adv (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:1000; tbl 3
In order to investigate evidence for two distinct pathogenetic pathways by studing the squamous cell carcinoma of the oral cavity and cytokeratin and protein expression patterns, Abcam CA9 antibody (Abcam, ab128883) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (tbl 3). Oncol Lett (2016) ncbi
domestic rabbit monoclonal (EPR4151(2))
  • western blot; human; fig 5
Abcam CA9 antibody (Abcam, ab108351) was used in western blot on human samples (fig 5). J Biol Chem (2016) ncbi
Novus Biologicals
domestic rabbit polyclonal (OTI2B3)
  • immunohistochemistry; human; loading ...; fig 6d
Novus Biologicals CA9 antibody (Novus Biologicals, NB100-417) was used in immunohistochemistry on human samples (fig 6d). Sci Adv (2021) ncbi
domestic rabbit polyclonal (OTI2B3)
  • immunohistochemistry; mouse; 1:1000; loading ...; fig 3a
Novus Biologicals CA9 antibody (Novus Biologicals, NB100-417) was used in immunohistochemistry on mouse samples at 1:1000 (fig 3a). NPJ Breast Cancer (2021) ncbi
domestic rabbit polyclonal (OTI2B3)
  • western blot; human; 1:5000; loading ...; fig 1f
Novus Biologicals CA9 antibody (Novus, NB100-417) was used in western blot on human samples at 1:5000 (fig 1f). EMBO Mol Med (2018) ncbi
domestic rabbit polyclonal (OTI2B3)
  • western blot; human; fig 13
Novus Biologicals CA9 antibody (Novus Biologicals, NB100-417) was used in western blot on human samples (fig 13). PLoS ONE (2016) ncbi
domestic rabbit polyclonal (OTI2B3)
  • immunohistochemistry - paraffin section; human; 1:2000; fig 6
In order to report angiopoietin-2 as a target in both naive and bevacizumab-treated glioblastoma, Novus Biologicals CA9 antibody (Novus Biologicals, #NB100?\417) was used in immunohistochemistry - paraffin section on human samples at 1:2000 (fig 6). EMBO Mol Med (2016) ncbi
domestic rabbit polyclonal (OTI2B3)
  • western blot; human; 1:1000; fig 4
In order to investigate factors that control PHD1 activity, Novus Biologicals CA9 antibody (Novus Biologicals, NB100-417) was used in western blot on human samples at 1:1000 (fig 4). J Cell Sci (2016) ncbi
domestic rabbit polyclonal (OTI2B3)
  • immunocytochemistry; Xenopus laevis; 1:500; fig 5c
  • western blot; Xenopus laevis; 1:500; fig 1e
  • immunocytochemistry; human; 1:500; loading ...; fig 5a
Novus Biologicals CA9 antibody (Novus Biologicals, NB100-417) was used in immunocytochemistry on Xenopus laevis samples at 1:500 (fig 5c), in western blot on Xenopus laevis samples at 1:500 (fig 1e) and in immunocytochemistry on human samples at 1:500 (fig 5a). FEBS J (2016) ncbi
Invitrogen
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:2000; loading ...; fig 2a
Invitrogen CA9 antibody (Thermo Fisher Scientific, PA1-16592) was used in immunohistochemistry on mouse samples at 1:2000 (fig 2a). Cancers (Basel) (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:400; loading ...; fig s4a
Invitrogen CA9 antibody (Invitrogen, PA1-16592) was used in immunohistochemistry - paraffin section on mouse samples at 1:400 (fig s4a). J Clin Invest (2021) ncbi
mouse monoclonal (GT12)
  • blocking or activating experiments; human; fig 8
  • western blot; human; 1:250; fig 6
In order to examine the metabolism of hypoxic SaOS-2 cells, Invitrogen CA9 antibody (Fisher Scientific, MA5-16318) was used in blocking or activating experiments on human samples (fig 8) and in western blot on human samples at 1:250 (fig 6). FEBS J (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (H-11)
  • immunohistochemistry; human; 1:100; fig 3c
Santa Cruz Biotechnology CA9 antibody (Santa Cruz, sc-365900) was used in immunohistochemistry on human samples at 1:100 (fig 3c). Cancer Res (2021) ncbi
OriGene
mouse monoclonal (OTI1G7)
  • immunohistochemistry - paraffin section; human; 1:150; loading ...; fig 1
OriGene CA9 antibody (Origene Technologies, OTI1G7) was used in immunohistochemistry - paraffin section on human samples at 1:150 (fig 1). BMC Cancer (2019) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D10C10)
  • western blot; mouse; fig 2d
Cell Signaling Technology CA9 antibody (Cell Signaling, 5648) was used in western blot on mouse samples (fig 2d). Sci Signal (2017) ncbi
domestic rabbit monoclonal (D47G3)
  • immunohistochemistry; human; 1:200
Cell Signaling Technology CA9 antibody (Cell Signaling, D47G3) was used in immunohistochemistry on human samples at 1:200. Int J Clin Exp Pathol (2015) ncbi
Articles Reviewed
  1. Hoefflin R, Harlander S, Abhari B, Peighambari A, Adlesic M, Seidel P, et al. Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma. Cancers (Basel). 2021;13: pubmed publisher
  2. Wang Y, Lyu Y, Tu K, Xu Q, Yang Y, Salman S, et al. Histone citrullination by PADI4 is required for HIF-dependent transcriptional responses to hypoxia and tumor vascularization. Sci Adv. 2021;7: pubmed publisher
  3. Ashok C, Ahuja N, Natua S, Mishra J, Samaiya A, Shukla S. E2F1 and epigenetic modifiers orchestrate breast cancer progression by regulating oxygen-dependent ESRP1 expression. Oncogenesis. 2021;10:58 pubmed publisher
  4. Nguyen Tran H, Nguyen T, Chen C, Hsu T. Endothelial Reprogramming Stimulated by Oncostatin M Promotes Inflammation and Tumorigenesis in VHL-Deficient Kidney Tissue. Cancer Res. 2021;81:5060-5073 pubmed publisher
  5. Carter P, Schnell U, Chaney C, TONG B, Pan X, ye J, et al. Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma. J Clin Invest. 2021;131: pubmed publisher
  6. Steenbrugge J, Vander Elst N, Demeyere K, De Wever O, Sanders N, van den Broeck W, et al. OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer. NPJ Breast Cancer. 2021;7:27 pubmed publisher
  7. Peck B, Bland P, Mavrommati I, Muirhead G, Cottom H, Wai P, et al. 3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer. Cancer Res. 2021;81:847-859 pubmed publisher
  8. Lan F, Yue X, Xia T. Exosomal microRNA-210 is a potentially non-invasive biomarker for the diagnosis and prognosis of glioma. Oncol Lett. 2020;19:1967-1974 pubmed publisher
  9. Chen W, Li W, Bai B, Wei H. Identification of anaplastic lymphoma kinase fusions in clear cell renal cell carcinoma. Oncol Rep. 2020;43:817-826 pubmed publisher
  10. Li J, Shi K, Sabet Z, Fu W, Zhou H, Xu S, et al. New power of self-assembling carbonic anhydrase inhibitor: Short peptide-constructed nanofibers inspire hypoxic cancer therapy. Sci Adv. 2019;5:eaax0937 pubmed publisher
  11. Bi C, Liu M, Rong W, Wu F, Zhang Y, Lin S, et al. High Beclin-1 and ARID1A expression corelates with poor survival and high recurrence in intrahepatic cholangiocarcinoma: a histopathological retrospective study. BMC Cancer. 2019;19:213 pubmed publisher
  12. Greenhough A, Bagley C, Heesom K, Gurevich D, Gay D, Bond M, et al. Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis. EMBO Mol Med. 2018;10: pubmed publisher
  13. CAROMILE L, Dortche K, Rahman M, Grant C, Stoddard C, Ferrer F, et al. PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer. Sci Signal. 2017;10: pubmed publisher
  14. Frohwitter G, Buerger H, van Diest P, Korsching E, Kleinheinz J, Fillies T. Cytokeratin and protein expression patterns in squamous cell carcinoma of the oral cavity provide evidence for two distinct pathogenetic pathways. Oncol Lett. 2016;12:107-113 pubmed
  15. Ono M, Yamada K, Bensaddek D, Afzal V, Biddlestone J, Ortmann B, et al. Enhanced snoMEN Vectors Facilitate Establishment of GFP-HIF-1α Protein Replacement Human Cell Lines. PLoS ONE. 2016;11:e0154759 pubmed publisher
  16. Black J, Zhang H, Kim J, Getz G, Whetstine J. Regulation of Transient Site-specific Copy Gain by MicroRNA. J Biol Chem. 2016;291:4862-71 pubmed publisher
  17. Scholz A, Harter P, Cremer S, Yalcin B, Gurnik S, Yamaji M, et al. Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma. EMBO Mol Med. 2016;8:39-57 pubmed publisher
  18. Ortmann B, Bensaddek D, Carvalhal S, Moser S, Mudie S, Griffis E, et al. CDK-dependent phosphorylation of PHD1 on serine 130 alters its substrate preference in cells. J Cell Sci. 2016;129:191-205 pubmed publisher
  19. Klier M, Jamali S, Ames S, Schneider H, Becker H, Deitmer J. Catalytic activity of human carbonic anhydrase isoform IX is displayed both extra- and intracellularly. FEBS J. 2016;283:191-200 pubmed publisher
  20. Müller W, Schröder H, Tolba E, Diehl Seifert B, Wang X. Mineralization of bone-related SaOS-2 cells under physiological hypoxic conditions. FEBS J. 2016;283:74-87 pubmed publisher
  21. Kuroda N, Agatsuma Y, Tamura M, Martinek P, Hes O, Michal M. Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma. Int J Clin Exp Pathol. 2015;8:2131-8 pubmed